Record PAT masked by one-time gain; input headwinds emerge
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Met FY26 guidance on outperformance and auto growth rates. Near-term margin guidance at risk given 100 bps QoQ compression despite pricing actions.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
SJS delivered record revenue and adjusted PAT growth of 45%, but headline PAT is 32% inflated by ₹241.7 Cr one-time facility sale gain. Core business momentum is solid (27 quarters of outperformance, strong export growth 83% YoY), but margin guidance of 27-28% is now at risk: EBITDA margin contracted 100 bps QoQ to 30% despite pricing claims, with 50-60 bps input cost headwind still only partially recovered. Long-term upside hinges on unproven ramps (BOE display from Q2 FY28, Decoplast 3-4 year ramp) with execution and margin profile TBD.
₹261 Cr
Revenue · +24.5% YoY₹74.4 Cr
Reported PAT · +115% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Highest-ever quarterly revenue and profitability since listing
OVERSTATED₹261 Cr revenue, ₹74.4 Cr PAT confirmed; however ₹241.7 Cr (32.5% of PAT) is one-time gain from old Bangalore facility sale
115% YoY PAT growth with strong operational performance
MISSAdjusted PAT excluding one-time gain is ₹50.3 Cr, +45.2% YoY; core operating profit growth is healthy but PAT headline inflated
EBITDA margin improved to 30% on product mix and export contribution
MISS30% EBITDA margin down ~100 bps QoQ from ~31% in Q4 FY26; despite pricing pass-through, input cost headwind of 50-60 bps was absorbed via operational efficiency, not margin expansion
Outperformed industry by 32.4% auto growth vs 21.7% industry growth (1.5x)
MET32.4% SJS auto growth vs 21.7% combined PV+2W industry is confirmed; sustained 27th consecutive quarter of outperformance is plausible
Gross margin stable despite inflation; pricing already being passed to customers
PartialQ4 56.6% vs Q1 56.7% gross margin (up only 0.1% QoQ). Pricing pass-through is in progress but lagged 1-2 quarters; only partial recovery visible
Earnings quality
What changed since the last call
Margin guidance reaffirmed despite QoQ compression
Neutral27-28% EBITDA margin guidance held despite 100 bps QoQ decline to 30% this quarter. Management cited new product ramp as offset but no numeric target revised. Prudent but cautious.
Export target reaffirmed at 14-15% by FY28
NeutralCurrently 9.8% of revenue; growing 83% YoY. Management confident on 'large businesses under discussion' but no firm orders disclosed vs prior call. Timeline held.
BOE display timeline on track but unvalidated
NeutralPlant commissioning Q2 FY28 as guided. Production samples at BOE for OEM field testing. No customer orders or ramp assumptions given; margin profile TBD pending manufacturing cost validation.
Decoplast capacity expansion accelerated; new facility commissioned Aug 2026
UpgradePune facility adds 200-250 Cr revenue capacity over 3 years; expect 85-90% utilization by year 3, 2-2.5x asset turn. Breakeven at 1-1.25x asset turn (likely Q2-3 of FY27).
The Q&A
Analysts pressed hard on margin sustainability (Chandramouli-Goldman Sachs): questioned 200 bps gross margin decline and timeframe to pass costs to customers. Management held line but selectively: admitted 50-60 bps input headwind, held pricing recovery is 1-2 quarter lagged. Analysts also sceptical on BOE display timing and exclusivity vs Pricol (Amit Jain). Management credibly clarified: 4-wheeler focus (larger market, higher margin) vs Pricol's 2-wheeler, and has exclusivity for 4-wheelers. Tone was confident but not dismissive of concerns.
Margin management and input costs — Chandramouli, Goldman Sachs
PartialMargins have improved, not declined. Gross margin Q4 56.6% vs Q1 56.7%, up 10 bps. Input cost headwind ~50-60 bps offset by richer product mix, export contribution, operational efficiency. Customer pricing negotiations ongoing; some wins already in place, some lagged 1-2 quarters.
Decoplast capacity utilization and returns — Chandramouli, Goldman Sachs
AnsweredAsset turn 2-2.5x at steady state (company-wide average >2x). Utilization 85-90% in 3 years. Breakeven at 1-1.25x asset turn (likely near end of FY27 or Q1 FY28). Order book very strong, bullish on prospects.
Cover glass and display business with BOE — Pranay Roop Chatterjee, Burman Capital
AnsweredEquipment on order, will ship and install. Sales start Q2 FY28 from new plant. Technical license with BOE; development samples currently with OEMs for testing. Orders expected after plant PPAP validation. Subsidiary structure leaves door open for JV if BOE wants to expand.
BOE supply chain and competitive positioning — Pranay Roop Chatterjee, Burman Capital
AnsweredBOE handles global development and prototyping; SJS handles India localization and assembly. Tripartite conversations (customer, BOE, SJS) on India supply timing. BOE leads technical phase, SJS executes local. This is exactly the model being followed.
Exports and Walter Pack growth — Pranay Roop Chatterjee, Burman Capital
PartialMultiple large businesses under discussion, good pipeline. Target still 14-15% exports by FY28. Advanced stage discussions happening across multiple technologies and geographies. Typical ramp during course of FY27. On track.
Cover glass TAM and margin expectations — Nitin Agrawal, JM Financial
PartialDisplay market (of which cover glass is part) currently ₹500-1000 Cr, expected to grow to ₹5000-7000 Cr by 2030. SJS aspiration: 10% market share by 2030. Margins higher than assembly margins; TBD when manufacturing starts. 50% of display is TFT (imported from BOE), 50% localized by SJS.
PV segment QoQ revenue decline — Pooja Sheth, YES Securities
AnsweredIndustry 4-wheeler segment declined 7.5% QoQ (Q4 to Q1). This is normal seasonality; Q1 soft period, demand picks up before festive sales in Q2. SJS PV grew 45.3% YoY. Strong overall.
EV content opportunity and two-wheeler prospects — Akshaj, Ashika Investment Managers
PartialLocalization of display/instrument cluster is the key; currently many Indian OEMs import from overseas. As EV volumes grow, investment in India localization will increase. Cover glass is additional opportunity. Volumes still low but growing rapidly; big lever for future growth.
Walter Pack Spain non-compete and export opportunity — Aditya Dayal, Zeva Consultants
AnsweredNon-compete till January 2027. Prefer cooperative agreement; Walter Pack Spain may not have capacity for everything. Could leverage partnership to co-operate. Theoretically can supply BMW, Audi, but till Jan 2027 cannot compete with Walter Pack Spain on these accounts.
Long-term growth outlook to 2030 — Nalin Shah, NVS Brokerage
PartialExtremely bullish. All building blocks in place (capacity, cash generation). By 2030 expect organic and inorganic growth. Exports major chunk of journey. Intentionally maximizing sales.
Walter Pack India capex and revenue targets post-utilization — Khush, Electrum PMS
DodgedWalter Pack operating at 75% capacity. Developing couple of new businesses. No immediate capex beyond normal maintenance. Will disclose further capex plan in future.
Guidance
FY27 outperform industry by 1.5x-2x; supported by order book covering 85%+ of forecast
High27 quarters of track record; automotive business 32.4% YoY growth vs 21.7% industry this quarter validates assumption
Sustain long-term EBITDA margins 27-28%; gated by new product ramp and premium mix
MediumQ1 EBITDA 30% down 100 bps QoQ; input costs 50-60 bps headwind not fully offset yet. New generation products 24% of revenue; upside contingent on volume.
Significant capacity expansions at Decoplast (₹200-250 Cr revenue over 3-4 years) and cover glass facility (Q2 FY28 start)
HighDecoplast Pune facility commissioned Aug 2026; breakeven at 1-1.25x asset turn. Cover glass equipment on order, PPAP runs to start when plant ready.
Risks the call surfaced
Margin compression from input inflation
MediumInput costs created 50-60 bps headwind Q1 FY27; pricing pass-through lagged 1-2 quarters. If recovery stalls, 27-28% EBITDA margin guidance at risk.
BOE display facility execution and timeline
MediumCover glass and display facility ramp-up dependent on BOE's global supply chain, customer approvals, and PPAP validation. No firm customer orders disclosed. Margin profile TBD. Delays could push revenue recognition to FY29.
Decoplast capacity absorption and timeline
MediumNew Pune facility adds 1.75x existing capacity with target 85-90% utilization over 3 years. Revenue ramp of ₹200-250 Cr over 3-4 years is contingent on order flow and export execution. Utilization slippage would hurt ROCE.
Automotive industry growth assumption
MediumFY27 guidance assumes automotive industry growth of 21.7% (passenger vehicle + 2-wheeler combined). If macro softens, SJS 1.5x-2x outperformance assumption may not hold. Industry growth has been lumpy; macro uncertainty (interest rates, consumer demand, supply chain).
Walter Pack new business ramp delay
LowNew businesses at Walter Pack have been 'under discussion' for 2+ quarters with tooling timelines repeatedly pushed. Revenue contribution still unclear; management non-committal on timing or magnitude.
Management
Score 7/10. Clear and transparent on numbers; disclosed one-time gain explicitly and provided adjusted PAT for comparability. Selective on future timelines (BOE margin, Walter Pack orders, Decoplast ramp); cites confidentiality but leaves gaps. 27 consecutive quarters of outperformance vs industry tracked and verified. Q1 FY27 revenue and adjusted PAT growth (45.2%) in line with expectations. Capacity expansion executed on schedule (Pune facility Aug 2026). Margin guidance held despite headwinds; prudent conservatism.
1 · Q2 FY28
SJS cover glass/display facility production ramp; BOE supplies test samples to OEM customers for validation
2 · FY27 full year
Walter Pack new business launch post-tooling completion; exports growth acceleration toward 14-15% target
3 · 3-4 years
Decoplast capacity addition of ₹200-250 Cr revenue, expected 85-90% utilization by year 3
Long-term upside hinges on unproven ramps (BOE display from Q2 FY28, Decoplast 3-4 year ramp) with execution and margin profile TBD.
Earnings Inflated by Asset Sale; Adjusted Growth Strong but Margins Compress
Reported PAT jumped 115% to ₹74.4 Cr, but ₹24.1 Cr is a one-time facility sale gain. The adjusted reality—₹50.3 Cr, +45% organic—reveals the real tension: strong operational outperformance offset by 100-basis-point margin compression and pricing-pass-through lags that management hasn't yet conquered.
₹74.4 Cr
+115% YoY
₹24.1 Cr
32.5% of PAT
₹50.3 Cr
+45.2% YoY (organic)
30%
−100 bps QoQ; guided 27–28%
S.J.S. Enterprises delivered record revenue of ₹261 Cr and reported PAT growth of 115%, but this quarter's earnings carry a critical asterisk. ₹24.1 Cr of the ₹74.4 Cr PAT comes from the sale of an unused Bangalore facility—a one-time, non-operational gain. Strip it out and the adjusted PAT is ₹50.3 Cr, up 45.2% organically. That's a healthy beat, but it masks a deeper problem: EBITDA margin compressed 100 basis points quarter-on-quarter to 30%, despite management claims of pricing power, and sits 200–300 basis points above the guided 27–28% long-term target. The gap is input-cost headwinds (50–60 bps) that pricing hasn't yet fully recovered.
Where the profit came from
Highest-ever quarterly revenue and profitability since listing.
₹261 Cr revenue confirmed; ₹74.4 Cr PAT is record headline, but ₹24.1 Cr is one-time facility sale—adjusted operating PAT ₹50.3 Cr is strong but not a step-change from prior quarters.
Overstated (headlines mislead)
115% YoY PAT growth with strong operational performance.
Headline growth inflated by one-time gain; adjusted PAT +45.2% YoY on solid auto outperformance (+32.4% vs. 21.7% industry).
Contradicted (adjusted reality)
EBITDA margin improved to 30% on product mix and export contribution.
30% EBITDA margin down 100 bps QoQ from 31%; margin compression despite pricing claims. Gross margin up only 10 bps (56.7% vs 56.6% QoQ); input cost headwind of 50–60 bps only partially offset.
Contradicted (margin declined)
Pricing already being passed to customers; gross margin stable.
Q4 gross margin 56.6% vs Q1 56.7%—10 bps improvement only. Pricing pass-through acknowledged as lagged 1–2 quarters; recovery only partial this quarter.
Partial (lag persists)
SJS outperforming industry by 1.5x (32.4% auto growth vs. 21.7% industry).
32.4% SJS auto growth vs. combined 21.7% PV + 2W industry growth confirmed. 27 consecutive quarters of outperformance tracked.
Supported (strong track record)
What changed on this call
Guidance reaffirmed, not raised. 27–28% EBITDA margin held despite 100 bps QoQ compression; timing to recover now pushed toward new product ramps (BOE, Decoplast).
Decoplast Pune facility commissioned Aug 2026 on schedule; adds ₹200–250 Cr revenue capacity over 3 years. Breakeven expected at 1–1.25x asset turn (likely near end of FY27 or Q1 FY28). Order book described as 'very strong.'
BOE cover glass & display facility on track for Q2 FY28 production start. Development samples now at OEM customers (Tier-1 suppliers and OEMs) for testing. Margin profile TBD post-PPAP validation.
Export growth accelerating: 9.8% of revenue, +83% YoY. Target 14–15% by FY28 held firm; 'large businesses under discussion' but no firm customer orders disclosed.
Walter Pack India new business (tooling delayed 2+ quarters) still under development; Mahindra confirmed as customer. Management non-committal on timing or magnitude.
The bull-bear ledger
27 consecutive quarters of automotive industry outperformance (1.5x multiple); organic PAT growth of +45.2% shows pricing power and cost discipline in core business.
Strong balance sheet: ₹3,287.7 Cr net cash; ROCE 37.2%, ROE 20.3%, free cash flow ₹838 Cr this quarter (101% of EBITDA). Capacity to invest and return capital.
Multiple growth levers in pipeline: BOE display (Q2 FY28 ramp, ₹5,000–7,000 Cr India TAM by 2030), Decoplast (₹200–250 Cr 3-year revenue add), export acceleration (target 14–15% by FY28), new product mix (24% of revenue now).
32% of Q1 PAT is a one-time facility sale gain, not operational. Reported growth headline masks organic reality: adjusted +45% is solid, but not the +115% the street initially reads.
EBITDA margin down 100 bps QoQ to 30%, and 200–300 bps above guided 27–28% long-term. Pricing pass-through lagged 1–2 quarters; only 10 bps of gross margin improvement despite claims of 'significant' pricing recovery. 50–60 bps input cost headwind still embedded.
New products (BOE display, Decoplast, Walter Pack new business) are execution-dependent, with no firm customer orders disclosed and timelines that have already slipped (Walter Pack tooling delayed 2+ quarters). Margin profile for BOE TBD.
Automotive industry growth assumption of 21.7% YoY this quarter validates 1.5x–2x outperformance guidance, but macro softness could erode baseline; SJS outperformance is dependent on industry growing 20%+.
Risks ranked by concern for a holder
EBITDA margin compression. 30% now vs. 27–28% guided; 100 bps QoQ decline despite pricing claims.
HighIf input cost recovery stalls and pricing pass-through remains lagged 1–2 quarters, guided margins fall out of reach. Earnings power is at risk if margins don't recover by Q2/Q3. Street likely reprices lower if guidance is revised down.
BOE display facility execution and timing. No customer orders disclosed; only development samples at OEMs. Margin profile TBD until manufacturing begins.
MediumRevenue recognition could slip beyond Q2 FY28 if PPAP validation delays or customer approvals stall. Margin upside is unproven; if manufacturing costs exceed expectations, new business margin could disappoint.
Decoplast capacity utilization. 3-year ramp to 85–90% utilization with ₹200–250 Cr revenue target contingent on export orders materializing.
MediumIf orders don't flow as expected, underutilization would drag ROCE and free cash flow. Order book cited as 'very strong' but not detailed.
Automotive industry growth slowdown. Q1 baseline was +21.7%; if macro cools, industry drops below 15–18% growth, SJS 1.5x–2x outperformance assumption becomes harder to sustain.
MediumValuation and growth guidance are anchored to automotive industry assumptions. Softness could cascade into SJS guidance revisions.
Walter Pack new business delays. 'Under discussion' for 2+ quarters; tooling timelines repeatedly pushed. No firm customer wins disclosed beyond Mahindra.
LowTiming uncertainty but not demand constraint; Walter Pack has 25% spare capacity. More of an execution question than a structural risk.
How the street is positioned
The stock opened to a muted +0.34% pop on day 1 after results, suggesting the market had already priced in strong auto outperformance. Price is now ₹2,372, down 8.4% from its all-time high of ₹2,589.6, but still +60.89% off the 52-week low and trading well above all key moving averages (SMA20 ₹2,324.56, SMA50 ₹2,216.54, SMA200 ₹1,851.39). RSI at 60.7 sits in neutral-to-overbought territory. Volume trend is increasing, suggesting institutional interest remains.
Ownership flows are sending mixed signals. DIIs accumulated +2.95 percentage points (31.09% → 34.04%), the largest quarterly inflow in the last year, and are now the single largest holder. FIIs, by contrast, trimmed −1.01 percentage points (15.68% → 14.67%)—a reversal after stable ownership through FY26 Q2–Q4. Promoters also reduced stake by −1.00pp (21.15% → 20.15%). The divergence matters: DIIs buying into margin pressure and one-time-gain headwinds suggests confidence in long-term positioning; FII exits in a muted post-result environment could reflect concern about near-term margin recovery or valuation at current levels.
1 · Q2 FY27 organic PAT and gross margin
Can pricing pass-through move faster than the lagged 1–2 quarters management cited? If gross margin stays flat and EBITDA margin re-compresses, the 27–28% guided range is in jeopardy. The adjusted PAT (ex one-time items) should be tracked, not the headline.
2 · BOE display revenue recognition and margin
Does Q2 FY28 production start materialize? Any customer order announcements? Margin profile should be disclosed before revenue recognition begins. This is the single largest unproven lever in guidance.
3 · Decoplast order flow and utilization trajectory
Over Q2–Q4 FY27, watch for new customer wins disclosed and capacity utilization commentary. If orders don't flow, expect management to guide down on the 3-year ₹200–250 Cr revenue ramp.
S.J.S. Enterprises delivered a quarter that proved consistency, not a step-change. The 27 consecutive quarters of outperformance, +45% adjusted PAT, and ₹3.3 Cr net cash position are all genuine strengths. But earnings quality matters: the ₹24.1 Cr one-time gain inflates perception, and the 100-basis-point margin compression is a real concern. Management's pricing power is proven over decades, but the 50–60 bps input cost headwind and lagged 1–2 quarter recovery window mean margins are at risk near-term. The stock's 8.4% drawdown from ATH and flat day-1 reaction suggest the market is cautious; DIIs accumulating against FII exits is a tell. Margins and the timing of new-product revenue ramps (BOE Q2 FY28, Decoplast ramp-up over 3 years) are the two numbers to watch. Track the adjusted PAT and gross margin recovery trajectory, not the headline PAT. Guidance holds, but execution on margins is now the credibility test.
SJS Q1 FY27: PAT +115% YoY on land-sale gain, +34% adjusted; margins expand to 30.6%
PAT +114.99% YoY · revenue +24.48% · margins expanding
₹261 Cr
+24.48% YoY
₹74.42 Cr
+114.99% YoY
27.95%
+11.7pp YoY
₹23.18
S.J.S. Enterprises posted consolidated revenue of ₹260.99 Cr (+24.5% YoY, +0.3% QoQ) and PAT of ₹74.42 Cr (+115.0% YoY, +52.3% QoQ) for Q1 FY27. The PAT print is flattered by a ₹27.95 Cr exceptional gain on the sale of a Bengaluru freehold land parcel for ₹58.5 Cr (announced June 15); stripping that one-off, adjusted PAT is ~₹46.5 Cr, up a steadier 34.2% YoY but down 4.9% QoQ, since Q4 FY26 carried no comparable one-off. Basic EPS was ₹23.18 (reported) against ₹15.16 in Q4 FY26 and ₹11.03 a year ago. No consensus/Street preview for this specific quarter turned up in search, so the print cannot be graded against a published estimate — vsStreet is unknown rather than assumed.
Q1 FY-2027 vs prior quarters
The more durable story is margins: operating margin (EBITDA/revenue, computed pre-exceptional) expanded to 30.6%, up from 28.7% in Q4 FY26 and 26.7% a year ago — running ahead of management's own 27-28% long-term EBITDA-margin guidance given on the May concall, and consistent with the mix/premiumization drivers management cited then. Adjusted net margin (ex the land-sale gain) was 17.8%, roughly flat versus 18.4% in Q4 FY26 and up from 16.3% YoY. Reported NPM of 28.5% is a one-off-inflated number and shouldn't be read as the underlying margin.
The stock went into the print at ₹2,520, up 13.6% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 5 consecutive quarters; revenue is at a 6-quarter high.
Management guides for FY27 revenue growth to outperform the underlying auto industry by 1.5x to 2x, supported by an order book covering over 85% of the forecast. The company aims to sustain long-term EBITDA margins in the 27-28% range, driven by a richer product mix, premiumization, and increasing exports to 14-15% of
— This quarter: beat
On revenue, management had guided FY27 growth to outperform the auto industry by 1.5-2x on an order book covering over 85% of forecast; +24.5% YoY consolidated growth is consistent with that framing though the underlying industry growth rate to benchmark against wasn't independently verified here. Consolidated growth outpaced standalone (+17.6% YoY, ₹145.53 Cr), a >3%-point divergence pointing to subsidiaries SJS Decoplast and Walter Pack (WPI) growing faster than the parent. Corporate action this quarter ties directly into that guidance: the board approved buying the remaining 9.9% of WPI (34,661 shares, ₹19.9 Cr) from Roy Mathew to make it wholly owned, and approved a new wholly-owned subsidiary (up to ₹10 Cr investment) to manufacture automotive displays — the vehicle for the BOE partnership management said would start contributing business in early FY28. Separately, SJS Decoplast announced a ₹100 Cr capacity expansion (13,243 sq ft/day) on August 4, consistent with the capacity-expansion plank of FY27 guidance, and the board declared a ₹3.50/share dividend (₹11.2 Cr) at the July 4 AGM. No management press release/commentary was available in the source set to cross-check against these numbers.
W1
Whether adjusted OPM holds near 30% next quarter or reverts toward the guided 27-28% range as the current mix/premiumization tailwind normalizes
W2
Completion of the balance 9.9% WPI stake buy and the new display-manufacturing WOS (BOE tie-up), which management said starts contributing business in early FY28
W3
Revenue growth cadence against the guided 1.5-2x-of-auto-industry target and export mix progress toward 14-15% of revenue by FY28
A ₹27.95 Cr exceptional item (net gain on sale of a Bengaluru freehold land/building, ₹58.5 Cr consideration, note 8) sits in both standalone and consolidated PBT/PAT — reported figures above include it. Non-controlling interest is immaterial (₹0.25 Cr of ₹74.42 Cr consol PAT). Source stated in ₹ Million, converted to ₹ Crore (÷10); conversion cross-checked against DB's Q4FY26/Q1FY26 comparison figures, which matched to the last decimal.